You have 9 free searches left this month | for more free features.

Condition

Healthy (1)

Rheumatoid Arthritis (1)

Systemic Lupus Erythematosus (1)

Overall Status

Completed (2)

Terminated (1)

Sign in for free

Phase

phase 2 (2)

phase 1 (1)

Sponsor

EMD Serono Research & Development Institute, Inc. (2)

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany (1)

Collaborator

Merck KGaA, Darmstadt, Germany (2)

Intervention

m2951 (3)

placebo (2)

midazolam (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

m2951

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Healthy Trial in Neu-Ulm (Midazolam, M2951)

Completed

Healthy

Midazolam
M2951

Neu-Ulm, Germany

Nuvisan GmbH

Mar 22, 2021

Systemic Lupus Erythematosus Trial in Worldwide (Placebo, M2951)

Terminated

Has Results

Systemic Lupus Erythematosus

Placebo
M2951

Anniston, Alabama
+156 more

Mar 16, 2021

Rheumatoid Arthritis Trial in Billerica, Darmstadt (Placebo, M2951)

Completed

Has Results

Rheumatoid Arthritis

Placebo
M2951

Billerica, Massachusetts
+1 more

Jun 18, 2018